These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23127888)

  • 21. Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition.
    Dossetter AG; Bowyer J; Cook CR; Crawford JJ; Finlayson JE; Heron NM; Heyes C; Highton AJ; Hudson JA; Jestel A; Krapp S; MacFaul PA; McGuire TM; Morley AD; Morris JJ; Page KM; Ribeiro LR; Sawney H; Steinbacher S; Smith C
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5563-8. PubMed ID: 22858142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of potent inhibitors of the human microsomal epoxide hydrolase.
    Barnych B; Singh N; Negrel S; Zhang Y; Magis D; Roux C; Hua X; Ding Z; Morisseau C; Tantillo DJ; Siegel JB; Hammock BD
    Eur J Med Chem; 2020 May; 193():112206. PubMed ID: 32203787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.
    Yuan W; Munoz B; Wong CH; Haeggström JZ; Wetterholm A; Samuelsson B
    J Med Chem; 1993 Jan; 36(2):211-20. PubMed ID: 8423594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1.
    Bravo Y; Teriete P; Dhanya RP; Dahl R; Lee PS; Kiffer-Moreira T; Ganji SR; Sergienko E; Smith LH; Farquharson C; Millán JL; Cosford ND
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4308-11. PubMed ID: 25124115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New class of azaheptapyridine FPT inhibitors as potential cancer therapy agents.
    Zhu HY; Desai J; Cooper AB; Wang J; Rane DF; Kirschmeier P; Strickland C; Liu M; Nomeir AA; Girijavallabhan VM
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1228-31. PubMed ID: 24462667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
    Cho HJ; Jung MJ; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid benzothiazole analogs as antiurease agent: Synthesis and molecular docking studies.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Khan KM; Riaz M
    Bioorg Chem; 2016 Jun; 66():80-7. PubMed ID: 27038849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of diversely substituted azacyclic inhibitors of endothelin converting enzyme.
    Hanessian S; Gauchet C; Charron G; Marin J; Nakache P
    J Org Chem; 2006 Mar; 71(7):2760-78. PubMed ID: 16555831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
    Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
    Penning TD; Russell MA; Chen BB; Chen HY; Liang CD; Mahoney MW; Malecha JW; Miyashiro JM; Yu SS; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    J Med Chem; 2002 Aug; 45(16):3482-90. PubMed ID: 12139459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of new (difluoromethylphosphono)azadisaccharides designed as bisubstrate analogue inhibitors for GlcNAc:beta-1,4 glycosyltransferases.
    Gautier-Lefebvre I; Behr JB; Guillerm G; Ryder NS
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1483-6. PubMed ID: 10888338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of soluble epoxide hydrolase activity by compounds isolated from the aerial parts of Glycosmis stenocarpa.
    Kim JH; Morgan AM; Tai BH; Van DT; Cuong NM; Kim YH
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):640-4. PubMed ID: 26444316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
    Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
    J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
    Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The design and synthesis of potent and cell-active allosteric dual Akt 1 and 2 inhibitors devoid of hERG activity.
    Siu T; Li Y; Nagasawa J; Liang J; Tehrani L; Chua P; Jones RE; Defeo-Jones D; Barnett SF; Robinson RG
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4191-4. PubMed ID: 18550373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of N-alkylated analogues of aza-galacto-fagomine - potential pharmacological chaperones for Krabbe disease.
    Viuff AH; Jensen HH
    Org Biomol Chem; 2016 Sep; 14(36):8545-56. PubMed ID: 27545315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach.
    Jo AR; Kim JH; Yan XT; Yang SY; Kim YH
    J Enzyme Inhib Med Chem; 2016; 31(sup2):70-78. PubMed ID: 27555350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.